Doing Business At the intersection of science, law, and policy

Your global business partners for addressing legal, scientific, and regulatory challenges.

Competitive Advantage

Bergeson & Campbell, P.C. (B&C®), is a Washington D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product approval and regulation, product defense, and associated business issues. 

We help companies that make and use chemicals commercialize their products, maintain compliance, and gain competitive advantage as they market their products throughout the world. Our Mission is to get them to market faster and more efficiently than the competition.

More About Us
Lab and planting seeds

Knowledge & Insights

  January 6, 2026
Memoranda
2026 Forecast for U.S. Federal and International Chemical Regulatory Policy

Download a PDF of the Forecast 2026. Bergeson & Campbell, P.C. (B&C®), its global consulting affiliate The Acta Group (Acta®), and consortia...

  December 29, 2025
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  January 17, 2026
Memoranda
House Releases Discussion Draft of Legislation to Modernize TSCA

On January 15, 2026, the House Energy and Commerce Subcommittee on Environment announced it will hold a legislative hearing on January 22, 2026,...

  January 15, 2026
Monthly Federal Developments Memorandum
Recent Federal Developments for January 2026

B&C, Acta, And BCCM Publish 2026 Forecast For U.S. Federal And International Chemical Regulatory Policy  Bergeson & Campbell, P.C....

  January 9, 2026
Memoranda
OEHHA Issues Information Letters Providing Prop 65 Guidance

In December 2025, the California Office of Environmental Health Hazard Assessment (OEHHA), the state agency responsible for implementing Proposition...

  January 7, 2026
Memoranda
EPA Publishes Final Risk Evaluation for 1,3-Butadiene, Intends to Regulate 11 COUs to Protect Workers

The U.S. Environmental Protection Agency (EPA) announced on January 5, 2026, the availability of the final risk evaluation under the Toxic Substances...

Seminars & Webinars

  December 29, 2025
Seminars & Webinars
What to Expect in Chemicals Policy and Regulation and on Capitol Hill in 2026, January 27, 2026, 11:00 a.m. – 12:00 p.m. (EST), via webinar

Register now to join Bergeson & Campbell, P.C. (B&C®) for “What to Expect in Chemicals Policy and Regulation and on Capitol Hill in...

  January 6, 2026
Seminars & Webinars
The FDA ISTAND Program: A Guide to Replacing Animal Experiments with Your Method, January 28, 2026, 1:00 p.m. (EST), via webinar

The Physicians Committee for Responsible Medicine (PCRM) presents "The FDA ISTAND Program: A Guide to Replacing Animal Experiments with Your Method."...

  October 29, 2025
Seminars & Webinars
TSCA Developments 2026, February 5, 2026, via webinar

Chemical Watch presents TSCA Developments 2026, covering TSCA and its business-critical implications, including risk evaluation and management rules,...

We partner with our clients to help them get products quickly and efficiently to market–in any country or locale–and keep them there.

Our Firms

our people

Government affairs experts, including five high-level EPA alumni. Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, and five Ph.D.'s. Trusted, respected, and highly rated attorneys who have worked on some of the toughest regulatory and legal issues of our time.

B&C, Acta, and BCCM provide a full range of global support for the commercialisation of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.

Hexagons image collage

A true business partner with clients, B&C delivers vital expertise in business strategy development, compliance planning, product defense, policy advocacy, and related activities.